Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
fda guidance on phase 1 clinical studies | 1.25 | 0.2 | 3965 | 9 |
phase 1 clinical trial fda guidance | 1.14 | 0.1 | 372 | 52 |
fda guidelines for phase 1 clinical trials | 1.19 | 0.8 | 8654 | 71 |
fda guidance for phase 1 | 1.28 | 0.5 | 9248 | 26 |
fda guidance for phase 2 clinical trials | 0.12 | 0.3 | 792 | 90 |
fda guidance on clinical studies | 1.73 | 0.6 | 5477 | 19 |
phase 1 clinical trials fda | 1.51 | 0.9 | 8944 | 71 |
fda phase 2 clinical trial guidance | 1.38 | 0.2 | 892 | 42 |
fda phase trials guidance | 1.83 | 0.7 | 8985 | 49 |
phase 1 ind fda guidance | 0.17 | 0.4 | 7258 | 80 |
fda guidance on clinical trials | 1.56 | 0.6 | 7287 | 50 |
fda phase 2 guidance | 0.17 | 0.3 | 4040 | 17 |
fda guidance for phase 1 manufacturing | 1.38 | 1 | 1261 | 84 |
fda phase 1 trials | 1.21 | 0.1 | 2186 | 13 |
clinical trial phase fda | 1.1 | 0.3 | 2635 | 49 |
phase appropriate guidance fda | 0.25 | 0.7 | 2958 | 98 |
phase i clinical trial guidance | 0.79 | 0.8 | 4562 | 62 |
phase 1 clinical trial guidelines | 1.56 | 0.9 | 6255 | 53 |
fda phases of clinical trials | 1.08 | 1 | 6536 | 35 |